Javier Valdivia

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Rafael Rosell, Enric Carcereny, Radj Gervais et al. · The Lancet Oncology · 2012 · 5.5K citations · Full text

Medicine, Oncology, Pharmacology +12

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

José Trigo, Vivek Subbiah, Benjamin Besse et al. · The Lancet Oncology · 2020 · 462 citations

Medicine, Oncology, Pharmacology +9

Totally endoscopic surgery on diastasis recti associated with midline hernias. The advantages of a minimally invasive approach. Prospective cohort study

Juan Antonio Bellido Luque, A Bellido Luque, Javier Valdivia et al. · Hernia · 2014 · 135 citations

Medicine, Gynecology, Surgery +14

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang et al. · Annals of Oncology · 2013 · 56 citations · Full text

Medicine, Oncology, Pharmacology +9

Metabolomic profile of cancer stem cell‐derived exosomes from patients with malignant melanoma

José Luis Palacios‐Ferrer, María Belén García‐Ortega, María Gallardo‐Gómez et al. · Molecular Oncology · 2020 · 53 citations · Full text

Medicine, Cell Biology, Oncology +17